(Q40243680)

18 September 2017

Role of E2F3 expression in modulating cellular proliferation rate in human bladder and prostate cancer cells (English)

1 reference

18 September 2017

1 reference

2

1 reference

18 September 2017

5

1 reference

18 September 2017

A Y Olsson

1

1 reference

18 September 2017

S Edwards

3

1 reference

18 September 2017

R Te Poele

4

1 reference

18 September 2017

S Merson

6

1 reference

18 September 2017

C S Cooper

7

1 reference

18 September 2017

language of work or name

English

0 references

publication date

14 August 2006

1 reference

18 September 2017

1 reference

18 September 2017

26

1 reference

18 September 2017

1028-1037

1 reference

18 September 2017

7

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1209854

18 September 2017

0 references

cites work

Molecular alterations in primary prostate cancer after androgen ablation therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

Prediction of lymph node metastasis in patients with endometrioid endometrial cancer using expression microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

Oncogenic pathway signatures in human cancers as a guide to targeted therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

Distinctions in the specificity of E2F function revealed by gene expression signatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

Identification of amplified and expressed genes in breast cancer by comparative hybridization onto microarrays of randomly selected cDNA clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part III. Proliferation in normal, injured and diseased tissue, growth factors, differentiation, DNA replication sites and in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

Analysis of gene function in somatic mammalian cells using small interfering RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

Amplification and overexpression of E2F3 in human bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

Transcription factor E2F3 overexpressed in prostate cancer independently predicts clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

High-resolution analysis of genomic copy number alterations in bladder cancer by microarray-based comparative genomic hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

Current status of the molecular genetics of human prostatic adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

What we could do now: molecular pathology of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

Deregulated E2F activity induces hyperplasia and senescence-like features in the mouse pituitary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

E2F3 activity is regulated during the cell cycle and is required for the induction of S phase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

Identification of a novel E2F3 product suggests a mechanism for determining specificity of repression by Rb proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

To cycle or not to cycle: a critical decision in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

Intravesical administration of small interfering RNA targeting PLK-1 successfully prevents the growth of bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

E2F3 amplification and overexpression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

E2F3a stimulates proliferation, p53-independent apoptosis and carcinogenesis in a transgenic mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

Loss of the retinoblastoma susceptibility gene (RB1) is a frequent and early event in prostatic tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

A molecular signature of metastasis in primary solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

p53, bcl-2 and retinoblastoma proteins as long-term prognostic markers in localized carcinoma of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

Caveolin-1, a metastasis-related gene that promotes cell survival in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

Polo-like kinase 1 is overexpressed in prostate cancer and linked to higher tumor grades.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

A rapid and convenient method for isolation of nuclear, cytoplasmic and total cellular RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

The E2F1-3 transcription factors are essential for cellular proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

Loss of p16 expression is of prognostic significance in locally advanced prostate cancer: an analysis from the Radiation Therapy Oncology Group protocol 86-10

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

7 January 2021

Detection of genetic alterations in bladder tumors by comparative genomic hybridization and cytogenetic analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

7 January 2021

Conditional deletion of Rb causes early stage prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

7 January 2021

Detection of chromosomal imbalances in papillary bladder tumors by comparative genomic hybridization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

7 January 2021

Chromosomal imbalances in small cell carcinomas of the urinary bladder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209854

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1209854

1 reference

Dimensions Publication ID

18 September 2017

0 references

1 reference